A peek behind the paper – Katy Peters on ibrutinib in primary central nervous system diffuse large B-cell lymphoma

Take a look behind the scenes of a recent Review article published in the journal CNS Oncology entitled, 'Ibrutinib in primary central nervous system diffuse B-cell lymphoma', as we ask corresponding author Katy Peters (Duke University Medical Center, NC, USA) about treatment options for primary central nervous system lymphoma (PCNSL), including the challenges yet to be overcome before ibrutinib could be approved for use in regular clinical practice.  What inspired you to write this review? PCNSL is a rare form of diffuse B-cell lymphoma that involves the brain, spinal cord, or leptomeninges, without evidence of systemic lymphoma and is responsible for only...